T-PLL is rare leukemia, and overall the prognosis is poor. T-PLL needs an interprofessional management approach with a medical oncologist, infectious disease physician, pharmacist, and oncology nurse, all working together as an interprofessional health team to bring about optimal clinical outcomes for the patient. [Level 5] The oncology nurse and pharmacist should educate the patient on the adverse effects of the chemotherapy drugs used to manage this leukemia to help drive the best possible patient outcomes.